223 related articles for article (PubMed ID: 8052940)
1. Radioiodine therapy during an unknown remained pregnancy and radiation exposure of the fetus. A case report.
Arndt D; Mehnert WH; Franke WG; Woller P; Laude G; Rockel A; Waller M
Strahlenther Onkol; 1994 Jul; 170(7):408-14. PubMed ID: 8052940
[TBL] [Abstract][Full Text] [Related]
2. Radioiodine treatment of hyperthyroidism in a pregnant women.
Berg GE; Nyström EH; Jacobsson L; Lindberg S; Lindstedt RG; Mattsson S; Niklasson CA; Norén AH; Westphal OG
J Nucl Med; 1998 Feb; 39(2):357-61. PubMed ID: 9476950
[TBL] [Abstract][Full Text] [Related]
3. "High-dose" radioiodine therapy in advanced differentiated thyroid carcinoma.
Menzel C; Grünwald F; Schomburg A; Palmedo H; Bender H; Späth G; Biersack HJ
J Nucl Med; 1996 Sep; 37(9):1496-503. PubMed ID: 8790201
[TBL] [Abstract][Full Text] [Related]
4. High-dose radioiodine treatment for differentiated thyroid carcinoma is not associated with change in female fertility or any genetic risk to the offspring.
Bal C; Kumar A; Tripathi M; Chandrashekar N; Phom H; Murali NR; Chandra P; Pant GS
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):449-55. PubMed ID: 16095849
[TBL] [Abstract][Full Text] [Related]
5. Radioiodine therapy for papillary and follicular thyroid carcinoma.
Klain M; Ricard M; Leboulleux S; Baudin E; Schlumberger M
Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S479-85. PubMed ID: 12192549
[TBL] [Abstract][Full Text] [Related]
6. [Genetic risk after high dose radioiodine therapy with regard to gonadal dose].
Ehrenheim C; Hauswirth C; Fitschen J; Martin E; Oetting G; Hundeshagen H
Nuklearmedizin; 1997 Aug; 36(5):157-66. PubMed ID: 9380527
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic administration of 131I for differentiated thyroid cancer: radiation dose to ovaries and outcome of pregnancies.
Garsi JP; Schlumberger M; Rubino C; Ricard M; Labbé M; Ceccarelli C; Schvartz C; Henri-Amar M; Bardet S; de Vathaire F
J Nucl Med; 2008 May; 49(5):845-52. PubMed ID: 18413399
[TBL] [Abstract][Full Text] [Related]
8. [Cytogenetic study of thyroid patients treated with external irradiation or radioiodine].
Katz N; Esik O; Füzy M; Gundy S
Orv Hetil; 1998 Jun; 139(25):1521-6. PubMed ID: 9676113
[TBL] [Abstract][Full Text] [Related]
9. Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal.
Hänscheid H; Lassmann M; Luster M; Thomas SR; Pacini F; Ceccarelli C; Ladenson PW; Wahl RL; Schlumberger M; Ricard M; Driedger A; Kloos RT; Sherman SI; Haugen BR; Carriere V; Corone C; Reiners C
J Nucl Med; 2006 Apr; 47(4):648-54. PubMed ID: 16595499
[TBL] [Abstract][Full Text] [Related]
10. Pregnancy outcome after diagnosis of differentiated thyroid carcinoma: no deleterious effect after radioactive iodine treatment.
Chow SM; Yau S; Lee SH; Leung WM; Law SC
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):992-1000. PubMed ID: 15234032
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy testing before high-dose radioiodine treatment: a case report.
Bohuslavizki KH; Kröger S; Klutmann S; Geiss-Tönshoff M; Clausen M
J Nucl Med Technol; 1999 Sep; 27(3):220-1. PubMed ID: 10512478
[TBL] [Abstract][Full Text] [Related]
12. Blood dosimetry from a single measurement of the whole body radioiodine retention in patients with differentiated thyroid carcinoma.
Hänscheid H; Lassmann M; Luster M; Kloos RT; Reiners C
Endocr Relat Cancer; 2009 Dec; 16(4):1283-9. PubMed ID: 19628649
[TBL] [Abstract][Full Text] [Related]
13. [Radioiodine therapy and radioiodine after-care in differentiated thyroid gland carcinomas].
Börner AR; Müller-Gärtner HW
Zentralbl Chir; 1997; 122(4):274-85. PubMed ID: 9221638
[TBL] [Abstract][Full Text] [Related]
14. Dosimetry and risk estimates of radioiodine therapy for large, multinodular goiters.
Huysmans DA; Buijs WC; van de Ven MT; van den Broek WJ; Kloppenborg PW; Hermus AR; Corstens FH
J Nucl Med; 1996 Dec; 37(12):2072-9. PubMed ID: 8970537
[TBL] [Abstract][Full Text] [Related]
15. [Diagnosis, treatment and follow-up in the case of differentiated thyroid cancer].
Lind P; Igerc I; Kohlfürst S
Wien Med Wochenschr; 2005 Oct; 155(19-20):429-35. PubMed ID: 16424998
[TBL] [Abstract][Full Text] [Related]
16. Improved prediction of therapeutic absorbed doses of radioiodine in the treatment of thyroid carcinoma.
Hermanská J; Kárný M; Zimák J; Jirsa L; Sámal M; Vlcek P
J Nucl Med; 2001 Jul; 42(7):1084-90. PubMed ID: 11438632
[TBL] [Abstract][Full Text] [Related]
17. Acute toxicity of adjuvant radiotherapy in locally advanced differentiated thyroid carcinoma. First results of the multicenter study differentiated thyroid carcinoma (MSDS).
Schuck A; Biermann M; Pixberg MK; Müller SB; Heinecke A; Schober O; Willich N
Strahlenther Onkol; 2003 Dec; 179(12):832-9. PubMed ID: 14652672
[TBL] [Abstract][Full Text] [Related]
18. Thyroperoxidase: a tumor marker for post-therapeutic follow-up of differentiated thyroid carcinomas? Results of a time course study.
Franke WG; Zöphel K; Wunderlich GR; Mat R; Kühne A; Schimming C; Kropp J; Bredow J
Cancer Detect Prev; 2000; 24(6):524-30. PubMed ID: 11198265
[TBL] [Abstract][Full Text] [Related]
19. Radiation dosimetry for the adult female and fetus from iodine-131 administration in hyperthyroidism.
Stabin MG; Watson EE; Marcus CS; Salk RD
J Nucl Med; 1991 May; 32(5):808-13. PubMed ID: 2022987
[TBL] [Abstract][Full Text] [Related]
20. Exposure to radioiodine in the preconception and conception periods. A case report.
Zaltzman S; Baron J; Werner A; Chaichik S
Isr J Med Sci; 1980 Dec; 16(12):856-8. PubMed ID: 7451114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
